Why is POCI Stock Down Today?
Company Description
Precision Optics Corporation, Inc. (NASDAQ: POCI) is a vertically integrated optics company that designs, develops and manufactures advanced optical instruments for the healthcare and defense/aerospace industries. Founded in 1982, the company focuses on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to support customers from new product concept through mass manufacture.
Within healthcare, Precision Optics works with next generation medical device companies that address the needs of the surgical community for more enhanced and smaller imaging systems used in minimally invasive surgery and in 3D endoscopy systems that support the proliferation of surgical robotic systems. The company has supplied top tier medical device companies with a variety of optical products for decades, including complex endocouplers and specialized endoscopes. According to additional disclosures, the company also manufactures medical products such as endoscopes and endocouplers for minimally invasive surgical and diagnostic procedures and designs and manufactures custom optical medical devices to meet specific customer requirements.
In the defense and aerospace markets, Precision Optics applies its micro-optics and imaging capabilities to applications that require high quality standards and careful optimization of size, weight and power. Recent company announcements describe work on sub-assemblies for advanced augmented reality (AR) systems for fighter pilot training and on a high-end, small-diameter borescope designed in multiple configurations to measure critical components inside jet engines in the field with greater-than-1080p HD resolution and performance in extreme environmental conditions. The company also manufactures and sells components and assemblies specially designed for industrial and military use.
Precision Optics emphasizes in-house capabilities that span design, prototyping, regulatory support and fabrication. It also utilizes the resources of its Ross Optical division, which provides high volume worldwide sourcing, inspecting and production resources. This combination allows the company to design and manufacture next-generation product solutions tailored to demanding customer requirements in both healthcare and defense/aerospace settings.
The company reports that it earns the majority of its revenue from the United States and that its business includes both engineering/development revenue and production revenue, reflecting its role in early-stage product development as well as ongoing manufacturing. Management communications highlight multi-year agreements with top tier aerospace and surgical robotics companies, as well as a growing production backlog that has led to facility expansion and additional production lines for specific customer programs.
Precision Optics has announced plans to move its corporate offices, including executive leadership, product development engineering, program management, human resources, business development and accounting, from Gardner, Massachusetts to Littleton, Massachusetts, while consolidating dedicated production capabilities at existing facilities in Gardner. The company has also referenced a facility in South Portland, Maine, which, together with the new Littleton site, is intended to provide access to a broader engineering talent pool to support its product development pipeline.
As part of its financial communications, Precision Optics discloses both GAAP results and a non-GAAP metric, Adjusted EBITDA, which excludes interest, taxes, depreciation, amortization and stock-based compensation. Management states that Adjusted EBITDA is used internally to compare operating performance over time and to evaluate business performance and trends.
Business model and revenue mix
According to company disclosures, Precision Optics generates revenue from engineering/development services and from production deliveries. Engineering revenue is tied to product development projects, such as AR sub-assemblies and jet engine borescopes, where the company provides design, prototyping and qualification services. Production revenue arises from manufacturing optical instruments, sub-assemblies and components, including single-use endoscope assemblies, complex endocouplers and specialized endoscopes, under ongoing customer programs and multi-year agreements.
Management commentary in recent financial results highlights the impact of multi-year agreements with a top tier aerospace company and a surgical robotics company, as well as increased production to meet growing demand from these customers. The company has also reported adding a second production line for single-use endoscope assemblies for a leading surgical company’s cystoscopy surgery system.
Industry positioning
Precision Optics operates at the intersection of surgical and medical instrument manufacturing and advanced optics for defense and aerospace. In healthcare, its focus on micro-optics, 3D imaging and digital imaging supports trends toward minimally invasive surgery and robotic-assisted procedures, where smaller, higher-performance imaging systems are required. In defense and aerospace, the company’s work on AR systems for pilot training and high-resolution borescopes for jet engines reflects demand for compact, high-performance optical systems that can function in challenging environments.
The company’s vertically integrated model, combining in-house design, prototyping, regulatory and fabrication with Ross Optical’s sourcing and production resources, is presented as a way to handle complex customer requirements from early concept through scaled manufacturing.
Key focus areas
- Healthcare imaging systems: Micro-optics, 3D imaging and digital imaging for minimally invasive surgery and 3D endoscopy, including complex endocouplers, specialized endoscopes and single-use endoscope assemblies.
- Surgical robotics support: Optical systems that support 3D endoscopy and imaging needs associated with the proliferation of surgical robotic systems.
- Defense and aerospace optics: Optical sub-assemblies for augmented reality systems for fighter pilot training, and high-end borescopes for jet engine inspection in extreme conditions.
- Industrial and military components: Components and assemblies designed for industrial and military use, drawing on the company’s micro-optics and imaging expertise.
- Engineering and production services: End-to-end support from new product concept and design through prototyping, regulatory-related work and mass manufacture.
Risk and disclosure practices
In its public communications, Precision Optics includes forward-looking statements regarding projections for revenue, gross margins and Adjusted EBITDA, and notes that these projections are subject to risks and uncertainties, including demand for the company’s products, global supply chains, economic conditions and other factors identified in its SEC filings. The company also provides reconciliations of non-GAAP measures, such as Adjusted EBITDA, to the most directly comparable GAAP measures in its financial tables.
Frequently asked questions about Precision Optics Corporation (POCI)
Stock Performance
Precision Optics (POCI) stock last traded at $4.19, down 0.83% from the previous close. Over the past 12 months, the stock has lost 4.7%. At a market capitalization of $32.5M, POCI is classified as a micro-cap stock with approximately 7.7M shares outstanding.
Latest News
Precision Optics has 10 recent news articles, with the latest published 3 days ago. Of the recent coverage, 1 article coincided with positive price movement and 7 with negative movement. Key topics include offering, earnings, conferences. View all POCI news →
SEC Filings
Precision Optics has filed 5 recent SEC filings, including 1 Form 4, 1 Form 424B5, 1 Form 8-K, 1 Form 10-Q. The most recent filing was submitted on March 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all POCI SEC filings →
Financial Highlights
Precision Optics generated $19.1M in revenue over the trailing twelve months, retaining a 17.8% gross margin, operating income reached -$5.6M (-29.1% operating margin), and net income was -$5.8M, reflecting a -30.3% net profit margin. Diluted earnings per share stood at $-0.85. The company generated -$3.5M in operating cash flow. With a current ratio of 1.64, the balance sheet reflects a strong liquidity position.
Upcoming Events
Offering expected close
Underwriter option period
Precision Optics has 2 upcoming scheduled events. The next event, "Offering expected close", is scheduled for March 30, 2026 (today). 2 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the POCI stock price.
Short Interest History
Short interest in Precision Optics (POCI) currently stands at 20.0 thousand shares, up 57.6% from the previous reporting period, representing 0.3% of the float. Over the past 12 months, short interest has increased by 131.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Precision Optics (POCI) currently stands at 1.0 days, down 35.1% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 22.8 days.
POCI Company Profile & Sector Positioning
Precision Optics (POCI) operates in the Medical Instruments & Supplies industry within the broader Electromedical & Electrotherapeutic Apparatus sector and is listed on the NASDAQ.
Investors comparing POCI often look at related companies in the same sector, including Retractable Tech (RVP), Milestone Scient (MLSS), Nephros Inc (NEPH), Harvard Biosci (HBIO), and Nexgel Inc (NXGL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POCI's relative position within its industry.